Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

RXRα is crucial for proper immune response and links diet to immune function.

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Bidara Arab leaves may help promote hair growth.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Pine resin and abietic acid were found to promote hair growth in mice.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Squaric acid dibutylester for alopecia areata can cause benign skin lymphoid growths.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

CARASIL, a rare genetic disorder, was confirmed in an Arabic woman, highlighting its rarity and need for stroke prevention.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Friedreich's ataxia causes thin, weak hair with surface damage and cavities.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

L. plantarum MTCC 1325 may help improve memory and cognitive functions in Alzheimer's.

JAK inhibitors may help improve symptoms in adults with APECED.

CAR is a useful marker for assessing alopecia areata severity.

Specific mutations in a receptor cause facial abnormalities and hair loss.